Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Document:EU ; GBR Regulation (EC) No 1223/2009 - Cosmetic Products 01-Dec-2023  + (12:15:22, 16 July 2026)
• Document:EU Regulation (EU) 910/2014 - electronic identification 17-Sep-2014  + (12:15:22, 16 July 2026)
• Document:EU ; GBR MDCG 2020-10/1 - Safety reporting in clinical investigations of medical devices 2020  + (12:15:22, 16 July 2026)
• Document:EU ; GBR Regulation (EC) No 178/2002 - Food Safety 01-Jul-2022  + (12:15:22, 16 July 2026)
• Document:FRA AEC-DM-DMDIV DOC006 v04 AAP RDM Partie II Modalités pratiques 16-May-2025  + (12:15:22, 16 July 2026)
• Document:FRA Code de la Santé Publique - Partie législative - 1ere partie, Livre 1er, Titre II 16-May-2025  + (12:15:22, 16 July 2026)
• Document:FRA Constitution du 4 octobre 1958 10-Mar-2024  + (12:15:23, 16 July 2026)
• Document:FRA Infographie - La hiérarchie des normes 22-Mar-2024  + (12:15:23, 16 July 2026)
• Document:FRA Guide de légistique 07-Feb-2024  + (12:15:23, 16 July 2026)
• Document:GBR Data Protection Act 2018 06-Jun-2022  + (12:15:23, 16 July 2026)
• Document:FRA SURV VIG DOC118 V01 REC-Avis aux promoteurs -Partie V 16-May-2025  + (12:15:23, 16 July 2026)
• Document:GBR Directive 2001/20/EC 04-Apr-2001  + (12:15:23, 16 July 2026)
• Document:GBR Directive 93/42/EEC 11-Oct-2007  + (12:15:23, 16 July 2026)
• Document:FRA SI RIPH 2G - Website 16-May-2025  + (12:15:23, 16 July 2026)
• Document:FRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007  + (12:15:23, 16 July 2026)
• Document:GBR Clinical investigations of medical devices – compiling a submission to MHRA May 2021  + (12:15:23, 16 July 2026)
• Document:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025  + (12:15:23, 16 July 2026)
• Document:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020  + (12:15:24, 16 July 2026)
• Document:GBR NHS: Records Management Code of Practice 07-Aug-2023  + (12:15:24, 16 July 2026)
• Document:GBR Guidance Managing clinical trials during Coronavirus (COVID-19) 16-Nov-.2021  + (12:15:24, 16 July 2026)
• Document:GBR MEDDEV 2.7/3 revision 3 May-2015  + (12:15:24, 16 July 2026)
• Document:GBR HRA - Ending your project 28-Jan-2025  + (12:15:24, 16 July 2026)
• Document:GBR Medicines and Medical Devices Act 2021 21-Feb-2021  + (12:15:24, 16 July 2026)
• Document:GBR IRAS - Integrated Research Application System 28-Jan-2025  + (12:15:24, 16 July 2026)
• Document:GBR NIHR - National Institute for Health and Care Research 28-Jan-2025  + (12:15:24, 16 July 2026)
• Document:GBR The Electronic Identification and Trust Services for Electronic Transactions (Amendment etc.) (EU Exit) Regulations 2019 23-Jan-2019  + (12:15:24, 16 July 2026)
• Document:GBR Guidance - Good clinical practice for clinical trials 16-Oct-2015  + (12:15:24, 16 July 2026)
• Document:GBR Making changes to a research study to manage the impact of COVID-19 12-Oct-2021  + (12:15:24, 16 July 2026)
• Document:GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447  + (12:15:24, 16 July 2026)

• Document:GBR The Human Medicines Regulations 2012 01-Jan-2025  + (12:15:25, 16 July 2026)
• Document:GBR The Medical Devices Regulations 2002 11-Feb-2021  + (12:15:25, 16 July 2026)
• Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004  + (12:15:25, 16 July 2026)
• Document:GBR UK GDPR - United Kingdom General Data Protection Regulation 31-Dec-2020  + (12:15:25, 16 July 2026)
• Document:USA 21 CFR Part 11 09-Apr-2025  + (12:15:25, 16 July 2026)
• Document:USA 21 CFR Part 314 09-Apr-2025  + (12:15:25, 16 July 2026)
• Document:USA 21 CFR Part 320 09-Apr-2025  + (12:15:25, 16 July 2026)
• Document:USA 21 CFR Part 50 09-Apr-2025  + (12:15:25, 16 July 2026)

• Document:USA 21 CFR Part 54 09-Apr-2025  + (12:15:26, 16 July 2026)
• Document:USA 21 CFR Part 56 09-Apr-2025  + (12:15:26, 16 July 2026)
• Document:USA 21 CFR Part 809 06-May-2024  + (12:15:26, 16 July 2026)
• Document:USA 21 CFR Part 812 09-Apr-2025  + (12:15:26, 16 July 2026)
• Document:USA 42 CFR Part 11 09-Apr-2025  + (12:15:26, 16 July 2026)
• Document:USA 45 CFR Part 160 09-Apr-2025  + (12:15:26, 16 July 2026)
• Document:USA 45 CFR Part 46 09-Apr-2025  + (12:15:26, 16 July 2026)
• Document:USA Acceptance of Clinical Data to Support Medical Device Applications and Submissions Frequently Asked Questions - Guidance for Industry and Food and Drug Administration Staff 21-Feb-2018  + (12:15:27, 16 July 2026)
• Document:USA CTCAE - Common Terminology Criteria for Adverse Events v5.0 (2017)  + (12:15:27, 16 July 2026)
• Document:USA Expedited Review: Categories of Research that may be Reviewed Through an Expedited Review Procedure 1998  + (12:15:27, 16 July 2026)
• Document:USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023  + (12:15:27, 16 July 2026)
• Document:USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018  + (12:15:27, 16 July 2026)
• Document:USA FDA - HUMAN DRUG CGMP NOTES Volume 8, Number 3  + (12:15:27, 16 July 2026)
• Document:USA FDA Guidance for Clinical Investigators, Sponsors, and IRBs Adverse Event Reporting to IRBs — Improving Human Subject Protection Jan-2009  + (12:15:27, 16 July 2026)
• Document:USA FDA Guidance for Industry - Computerized Systems Used in Clinical Investigations May-2007  + (12:15:27, 16 July 2026)
• Document:USA FDA Guidance for Industry - Computerized Systems Used in Clinical Trials 13-Apr-2015  + (12:15:27, 16 July 2026)
• Document:USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020  + (12:15:27, 16 July 2026)
• Document:USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013  + (12:15:27, 16 July 2026)
• Document:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013  + (12:15:28, 16 July 2026)
• Document:USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009  + (12:15:28, 16 July 2026)
• Document:USA FDA INFORMATION SHEET - Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators Jan-1998  + (12:15:28, 16 July 2026)